36 Best Pharma Startups in London to Watch in 2025

The Definitive Seedtable Ranking of Pharma Startups in London

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 36 start-ups with an aggregate funding of $2.4b. The average funding per company in this subset is $66.7m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

15

Funding Rounds

$140.4m

Money raised

Synthace is a software company based out of London, UK, building automation software that gives biologists the ability to control and analyze the performance of lab hardware.

6

Funding Rounds

$190.5m

Money raised

Kuur Therapeutics focuses on the development of CAR-NKT cell therapies platform for applications in cancer treatment.

6

Funding Rounds

$86.6m

Money raised

Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.

Location:

Key people:

10

Funding Rounds

$187.8m

Money raised

Causaly is a biomedical research discovery tool founded in 2018 by Yiannis Kiachopoulos.

Location:

Key people:

5

Funding Rounds

$82.8m

Money raised

Peptome is a London-based protein physics intelligence company founded in 2016 by Kamil Tamiola and Matt Heberling. It utilizes artificial intelligence for computers to process all information about protein data in the same efficient way that scientists do.

Location:

Key people:

10

Funding Rounds

$62.4m

Money raised

A software solutions company providing bioinformatics solutions to life science and other sector

6

Funding Rounds

$133.6m

Money raised

Intelligent, distributed & reproducible big data & genomics analysis at scale. Zero onboarding. Zero config.

2

Funding Rounds

$155.0m

Money raised

Digital health platform for predictive care and research.

3

Funding Rounds

$126.0m

Money raised

Health technology startup that creates personalized behavioral medicine programs

5

Funding Rounds

$50.1m

Money raised

Tatum is a blockchain developer platform. It offers products such as NFT plug-ins for Wordpress, software development kits for over 40 protocols and an API that enables NFT minting across various blockchains.

2

Funding Rounds

$44.0m

Money raised

BC Platforms provide data management systems for clinical and genomic research, pharmacogenomics research, preventive and personalized medicine, and biobanking.

Industries:

Location:

3

Funding Rounds

$45.5m

Money raised

A company offering a medication management platform that gives insight into patient behavior.

5

Funding Rounds

$111.1m

Money raised

Medication and supplements provider for men’s health conditions.

Location:

Key people:

3

Funding Rounds

$41.0m

Money raised

We're a next gen CRO running end-to-end clinical trials for health and biotech pioneers. From trial design to recruitment and delivery, we accelerate trials.

Location:

Key people:

3

Funding Rounds

$115.0m

Money raised

Platform for AI-driven drug discovery in clinical-stage development.

Key people:

1

Funding Rounds

$45.5m

Money raised

Silence Therapeutics is a London-based company founded in 1999.

Location:

Key people:

1

Funding Rounds

$34.2m

Money raised

Avacta Group PLC is a drug Development Platform, Engineered Antibodies founded in 2012.

1

Funding Rounds

A pharmaceutical company specializing in drug candidates used for in out-patient and hospital-based sedation

2

Funding Rounds

$15.2m

Money raised

Personalized cancer treatment company

7

Funding Rounds

$117.3m

Money raised

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Location:

5

Funding Rounds

$178.8m

Money raised

Ori Biotech is a cell & Gene Therapy Manufacturing founded in 2015.

2

Funding Rounds

$51.0m

Money raised

Medopad is an artificial Intelligence company founded in 2011 by Dan Vahdat.

1

Funding Rounds

Tecrea is a biotech company in the United Kingdom founded in 2012 by Fernando Velez.

3

Funding Rounds

$256.0m

Money raised

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

2

Funding Rounds

$7.8m

Money raised

Veratrak is a blockchain company founded in 2018 by Jason Lacombe.

1

Funding Rounds

$1.8m

Money raised

Pharmacierge provide a service for patients to have their prescription medicines delivered to their door at home or work within hours of being prescribed.

Location:

Key people:

2

Funding Rounds

$7.8m

Money raised

Marketplace offering convenient online access to Health and Wellness products.

2

Funding Rounds

$24.1m

Money raised

MedicAnimal is a Willesden-based company founded in 2007.

1

Funding Rounds

$23.0m

Money raised

MiNA Therapeutics is a small activating RNA founded in 2008.

1

Funding Rounds

$130.0k

Money raised

Nuntius Therapeutics is a cell-specific DNA, RNA and CRISPR therapies founded in 2021 by Albert Kwok.

Location:

Key people:

3

Funding Rounds

$33.9m

Money raised

Small Molecules

1

Funding Rounds

$130.0k

Money raised

On a mission to power the pharmacy of the future, giving people the confidence to make the most of their medicines.

1

Funding Rounds

$15.8m

Money raised

Leucid Bio is a cell Therapy.

1

Funding Rounds

StablevaX™ platform provider for fridge-free vaccine and pharmaceutical products.

1

Funding Rounds

$6.9m

Money raised

Ignota Labs is an AI-driven drug discovery platform founded in 2021 by Sam Windsor, Layla Hosseini Gerami and Jordan Lane.

Key people:

2

Funding Rounds

$10.9m

Money raised

Macrophage Pharma is a small Molecule Immunotherapy.

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.